Description: A polyclonal antibody for detection of TERF2 from Human, Mouse. This TERF2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human TERF2 protein at amino acid sequence of 130-210

Description: A polyclonal antibody for detection of TERF2 from Human, Mouse. This TERF2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human TERF2 protein at amino acid sequence of 130-210

Description: A polyclonal antibody for detection of TERF2 from Human, Mouse. This TERF2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human TERF2 protein at amino acid sequence of 130-210

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TERF2 . This antibody is tested and proven to work in the following applications:

Description: A sandwich quantitative ELISA assay kit for detection of Human Telomeric Repeat Binding Factor 2 (TERF2) in samples from tissue homogenates, cell lysates or other biological fluids.

Description: A sandwich quantitative ELISA assay kit for detection of Human Telomeric Repeat Binding Factor 2 (TERF2) in samples from tissue homogenates, cell lysates or other biological fluids.

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TERF2 (Center). This antibody is tested and proven to work in the following applications:

Description: A polyclonal antibody raised in Goat that recognizes and binds to Human TERF2 / TRF2 . This antibody is tested and proven to work in the following applications:

Description: A polyclonal antibody against TERF2. Recognizes TERF2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

Description: A polyclonal antibody against TERF2. Recognizes TERF2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

Description: A polyclonal antibody against TERF2. Recognizes TERF2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IF:1:50-1:200

Description: A polyclonal antibody against TERF2. Recognizes TERF2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB

Description: Rabbit polyclonal TERF2 antibody

Description: Rabbit polyclonal TERF2 antibody

Description: The telomeric repeat binding factor family (TERF1 and TERF2) plays a key role in cellular immortalization and cellular senescence (1). TERF2, as a component of the telomere nucleoprotein complex, is present at telomeres in metaphase of the cell cycle (2). TERF2 is a second negative regulator of telomere length and binds as a dimer to TTAGGG repeats at ends of chromosomes (telomeres), where it blocks inappropriate activation of the ATM/p53 pathway (2,3). TERF1 negatively regulates telomere elongation, while TERF2 protects the chromosome ends by inhibiting end-to-end fusions. Down-regulation of TRF expression in tumor cells may contribute to cell immortalization and malignant progression (4,5).

Description: The telomeric repeat binding factor family (TERF1 and TERF2) plays a key role in cellular immortalization and cellular senescence (1). TERF2, as a component of the telomere nucleoprotein complex, is present at telomeres in metaphase of the cell cycle (2). TERF2 is a second negative regulator of telomere length and binds as a dimer to TTAGGG repeats at ends of chromosomes (telomeres), where it blocks inappropriate activation of the ATM/p53 pathway (2,3). TERF1 negatively regulates telomere elongation, while TERF2 protects the chromosome ends by inhibiting end-to-end fusions. Down-regulation of TRF expression in tumor cells may contribute to cell immortalization and malignant progression (4,5).

Description: Antibody raised against TERF2

Description: This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres. While having similar telomere binding activity and domain organization, TERF2 differs from TERF1 in that its N terminus is basic rather than acidic.

Description: Unconjugated Rabbit polyclonal to TERF2